Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • BIOMARIN PHARMACEUTICAL INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 565.99 M 585.59 M 288.85 M 47.79 M 74.11 M
    Net Receivables 89.30 M 19.06 M 16.27 M 6.93 M 6.21 M
    Total Inventories 73.16 M 32.44 M 25.08 M 10.90 M 2.32 M
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses 6.89 M — — — —
    Other Current Assets 2.35 M 7.20 M 4.04 M 3.32 M 2.64 M
    Current Assets Total 737.70 M 644.30 M 334.22 M 68.94 M 85.28 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 915,000.00 44.88 M 31.46 M 31.98 M 23.13 M
    Other Investments 2.73 M 2.89 M 0.00 0.00 0.00
    Property, Plant & Equipment Net 124.98 M 76.82 M 55.47 M 37.32 M 42.50 M
    Property, Plant & Equipment Gross 171.06 M 111.63 M 82.52 M 80.83 M 80.44 M
    Accumulated Depreciation 46.08 M 34.81 M 27.05 M 43.51 M 37.94 M
    Other Assets 40.37 M 46.39 M 42.29 M 57.06 M 82.06 M
    Deferred Charges 8.50 M — — — —
    Tangible Other Assets 11.48 M 7.04 M 9.37 M 20.49 M 20.56 M
    Intangible Other Assets 28.89 M 30.86 M 32.92 M 36.57 M 61.50 M
    Total Assets 906.70 M 815.28 M 463.44 M 195.30 M 232.97 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 3.86 M 3.68 M 2.72 M 2.51 M —
    Accrued Payroll 15.54 M 10.79 M 6.30 M 4.22 M 4.68 M
    Income Taxes Payable — — — — —
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 113.62 M 49.58 M 37.46 M 21.78 M 47.09 M
    Current Liabilities Total 130.08 M 61.54 M 46.04 M 40.37 M 70.05 M
    Long Term Debt 497.35 M 497.38 M 223.94 M 142.05 M 141.41 M
    Provision for Risks & Charges 5.68 M — — — —
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 1.18 M 1.64 M 6.26 M 13.79 M 0.00
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 1.41 M 67.00 M 69.39 M 70.87 M 89.48 M
    Total Liabilities 630.02 M 627.55 M 345.63 M 272.76 M 300.94 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 276.68 M 187.73 M 117.80 M -77.46 M -67.98 M
    Common Stock 100,000.00 97,000.00 92,000.00 75,000.00 65,000.00
    Capital Surplus 852.95 M 794.92 M 709.36 M 485.57 M 421.14 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 224,000.00 139,000.00 -25,000.00 -16,000.00 -363,000.00
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -576.60 M -607.43 M -591.62 M -563.09 M -488.82 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) -18,000.00 -67,000.00 — — —
    Unrealized Gain (Loss) on Marketable Securities 1,000.00 394,000.00 — — —
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 906.70 M 815.28 M 463.44 M 195.30 M 232.97 M
    Common Shares Outstanding 99.87 M 97.11 M 91.73 M 74.30 M 64.50 M